“Next Generation EC-Based Allograft Technology: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient’s own stem cells and improve surgical outcomes.” – Lattice Biologics, 2015.
“Generating Extracellular Matrix for Tissue Culture Applications.” – Christopher Bradley, Ph.D. (Lattice Biologics Project Manager & Product Development Director) 2015.
“Aptamer Technology: The key to unlocking advanced healing through true personalized medicine.” – Lattice Biologics, 2015.
“Aptamers as Markers of Cell Viability in Regenerative Medicine.” – Christopher Bradley, Ph.D. (Lattice Biologics Project Manager & Product Development Director) 2015.
“Team Effort: Using aggressive surgical techniques in combination with AdMatrix to heal difficult and persistent wounds.” (A review of Dr. Dinakar Golla’s clinical research with AdMatrix surgical grafts for soft tissue repair.) – Lattice Biologics, 2015.
“Mirror Image: The future of cancer diagnostics may be closer than it appears.” (Advanced molecular techniques, fluorescence, and reconstruction of the tumor microenvironment.) – Lattice Biologics, 2015.
“Aging & Lifespan: Lore, Legends, and Theories.” (Understanding the hallmarks of aging and deploying stem cell therapies and parabiosis techniques to promote rejuvenation in the battle for youth.) – Lattice Biologics, 2015.
“Cartilage Repair: Tackling the perplexing challenges of articular cartilage regeneration.” (An overview of this area’s unique issues, treatment methods, and our ECM-Loaded Allograft Technology.) – Lattice Biologics, 2015.